Walgreens Boots Alliance Inc
NASDAQ:WBA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.85
12.93
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
WBA
stock under the Base Case scenario is
31.91
USD.
Compared to the current market price of 11.98 USD,
Walgreens Boots Alliance Inc
is
Undervalued by 62%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Walgreens Boots Alliance Inc.
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
|
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Mounting competition from e-pharmacies and large retailers (e.g., Amazon, Walmart) is pressuring Walgreens Boots Alliance’s traditional brick-and-mortar model, threatening to erode both prescription volume and front-end retail sales.
Walgreens’ heavy exposure to government reimbursement and the complex regulatory environment in both the U.S. and international markets could further compress margins as payers push for lower drug prices and reduced pharmacy dispensing fees.
Ongoing cost-cutting measures and store optimization efforts may stifle near-term growth if they disrupt customer convenience or weaken the in-store experience, undermining the company’s brand power and patient loyalty.
Walgreens’ strong brand recognition and expansive store footprint in key markets (the U.S. and United Kingdom) position it as a trusted pharmacy destination, enabling the company to capture prescriptions and front-end sales despite competitive pressures.
Investments in VillageMD, Shields Health Solutions, and other healthcare service ventures broaden Walgreens’ offerings beyond retail dispensing, potentially driving higher-margin services and recurring patient engagement over the long run.
Expansion of digital capabilities, including online prescription fulfillment and same-day delivery, could help Walgreens capture online market share and integrate seamlessly with its extensive physical presence, reinforcing customer loyalty.
Revenue & Expenses Breakdown
Walgreens Boots Alliance Inc
Balance Sheet Decomposition
Walgreens Boots Alliance Inc
| Current Assets | 15.7B |
| Cash & Short-Term Investments | 830m |
| Receivables | 6.6B |
| Other Current Assets | 8.3B |
| Non-Current Assets | 53.7B |
| Long-Term Investments | 1.3B |
| PP&E | 27.8B |
| Intangibles | 22.7B |
| Other Non-Current Assets | 2B |
| Current Liabilities | 26B |
| Accounts Payable | 13.6B |
| Accrued Liabilities | 11.6B |
| Other Current Liabilities | 738m |
| Non-Current Liabilities | 36.3B |
| Long-Term Debt | 7.8B |
| Other Non-Current Liabilities | 28.4B |
Free Cash Flow Analysis
Walgreens Boots Alliance Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Walgreens Boots Alliance Inc
|
Revenue
|
154.6B
USD
|
|
Cost of Revenue
|
-128.1B
USD
|
|
Gross Profit
|
26.5B
USD
|
|
Operating Expenses
|
-23.1B
USD
|
|
Operating Income
|
3.4B
USD
|
|
Other Expenses
|
-9.7B
USD
|
|
Net Income
|
-6.3B
USD
|
WBA Profitability Score
Profitability Due Diligence
Walgreens Boots Alliance Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Walgreens Boots Alliance Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
WBA Solvency Score
Solvency Due Diligence
Walgreens Boots Alliance Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Score
Walgreens Boots Alliance Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WBA Price Targets Summary
Walgreens Boots Alliance Inc
Dividends
Current shareholder yield for
WBA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
WBA
stock under the Base Case scenario is
31.91
USD.
Compared to the current market price of 11.98 USD,
Walgreens Boots Alliance Inc
is
Undervalued by 62%.